drugset / Trial / NCT03559348
Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Phase 2
Completed
49 enrolled
National Health Research Institutes, Taiwan
Chang Gung Memorial Hospital · collabChina Medical University Hospital · collabKaohsiung Medical University · collabNational Cheng-Kung University Hospital · collabNational Taiwan University Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
Multiple centers, uncontrolled, open-label, non-randomized single-arm study
Timeline
- Start
- 2018-04-03
- Primary completion
- 2020-04-20
- Completion
- 2020-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 800 mg/m2 | — |
| Subject | Leucovorin | Small molecule | 60 mg | Oral |
| Subject | TS-1 | Small molecule | 80 mg | Oral |
| Subject | TS-1 | Small molecule | 100 mg | Oral |
| Subject | TS-1 | Small molecule | 120 mg | Oral |